| Active substance |
AmlodipineValsartan |
| Also known as |
Amlodipine besylate (when paired with besylate salt) |
| Blood pressure |
Reduces blood pressure |
| Chemical name |
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Dosage (medical) |
5-10 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Lowering of blood pressure, improvement in blood flow |
| Formula |
C20H25ClN2O5 |
| Half-life |
30-50 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specifically required for monitoring amlodipine |
| Main action |
Dilation of blood vessels (vasodilation) |
| Side effects |
Headache, swelling (edema), fatigue, dizziness, palpitations, flushing |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Calcium channel blocker |
| Trade name |
Norvasc, among others |
| Use in sports |
Not typically used in sports |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
Possible, particularly ankle and foot swelling |
| Manufacturer |
Novartis |
